The Effect of Dexmedetomidine Infusion on Oxygen Consumption and Energy Expenditure in Critically Ill Patients
PDF
Cite
Share
Request
Original Research
P: 209-214
December 2019

The Effect of Dexmedetomidine Infusion on Oxygen Consumption and Energy Expenditure in Critically Ill Patients

J Turk Soc Intens Care 2019;17(4):209-214
1. Tepecik Eğitim ve Araştırma Hastanesi, Anesteziyoloji ve Reanimasyon Kliniği, İzmir, Türkiye
2. Ege Üniversitesi Tıp Fakültesi, Anesteziyoloji ve Reanimasyon Anabilim Dalı, İzmir, Türkiye
No information available.
No information available
Received Date: 05.11.2018
Accepted Date: 07.02.2019
Publish Date: 08.10.2019
PDF
Cite
Share
Request

ABSTRACT

Objective:

Anxiety may have deleterious effects by increasing oxygen consumption (VO2) and energy expenditure (EE) in mechanically ventilated patients. The effects of dexmedetomidine, a selective alpha-2 agonist sedative, have not been studied in critically ill patients in this respect. In this study, the effects of dexmedetomidine on VO2 and EE in mechanically ventilated critically ill patients were investigated by indirect calorimetry.

Materials and Methods:

All patients served as their own control. Before commencing dexmedetomidine infusion, baseline values of all parameters were recorded. Then, following a bolus dexmedetomidine dose of 1 μg/kg, infusion started at a dose of 0.2-0.7 μg/kg/h. Sedation was maintained for two hours with dexmedetomidine, which was titrated to provide moderate sedation according to bispectral index (BIS) score. BIS score was aimed to be kept between 60-70 throughout the study. We measured VO2, carbon dioxide production (VCO2) and EE by indirect calorimetry method for two hours during dexmedetomidine infusion. The study was completed after dexmedetomidine infusion was stopped and the measurements were repeated at the first, second, and third hours.

Results:

Fifteen patients participated in the study. The mean age was 48±16 years and the mean APACHE 2 score was 14.8±6.2. During dexmedetomidine infusion, VO2, EE and VCO2 decreased significantly compared to baseline (p<0.05). After the discontinuation of dexmedetomidine, all variables approached to their baseline values.

Conclusion:

We concluded that dexmedetomidine attenuated metabolic stress response in critically ill patients and cessation of sedation was followed by increases in VO2 and EE.

Keywords: Intensive care, sedation, dexmedetomidine, oxygen consumption, energy expenditure

References

1
Weledji EP, Assob JC. The systemic response to surgical trauma-a review. East and Central African Journal of Surgery 2012;17:3-12.
2
Desborough JP. The stress response to trauma and surgery. Br J Anaesth 2000;85:109-17.
3
Van den Berghe G. The neuroendocrine response to stress is a dynamic process. Best Pract Res Clin Endocrinol Metab 2001;15:405-19.
4
De Gaudio AR, Bonifazi M, Romagnoli S. The Stress Response of Critical Illness: Which Is the Role of Sedation?. In: De Gaudio AR, Romagnoli S, editors. Critical Care Sedation; Springe, Cham: 2018.p.9-19.
5
Cooney RN, Frankenfield DC. Determining energy needs in critically ill patients: equations or indirect calorimeters. Current Opin Crit Care 2012;18:174-7.
6
Kress JP, O’Connor MF, Pohlman AS, Olson D, Lavoie A, Toledano A, et al. Sedation of critically ill patients during mechanical ventilation. A comparison of propofol and midazolam. Am J Respir Crit Care Med 1996;153:1012-8.
7
Vernon DD, Witte MK. Effect of neuromuscular blockade on oxygen consumption and energy expenditure in sedated, mechanically ventilated children. Crit Care Med 2000;28:1569-71.
8
Terao Y, Miura K, Saito M, Sekino M, Fukusaki M, Sumikawa K. Quantitative analysis of the relationship between sedation and resting energy expenditure in postoperative patients. Crit Care Med 2003;31:830-3.
9
Venn M, Newman J, Grounds M. A phase II study to evaluate the efficacy of dexmedetomidine for sedation in the medical intensive care unit. Itensive Care Med 2003;29:201-7.
10
Keating GM. Dexmedetomidine: A Review of Its Use for Sedation in the İntensive Care Setting. Drugs. 2015;75:1119-30.
11
Jakob SM, Ruokonen E, Grounds RM, Sarapohja T, Garratt C, Pocock SJ, ve ark. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: Two randomized controlled trials. Jama 2012;307:1151-60.
12
Riker RR, Shehabi Y, Bokesch PM, Ceraso D, Wisemandle W, Koura F, ve ark. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. Jama 2009;301:489-99.
13
Pandharipande PP, Pun BT, Herr DL, Maze M, Girard TD, Miller RR, ve ark. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. Jama 2007;298:2644-53.
14
Avidan MS, Zhang L, Burnside BA, Finkel KJ, Searleman AC, Selvidge JA, ve ark. Anesthesia awareness and the bispectral index. N Engl J Med 2008;358:1097-108.
15
Zhang Z, Chen K, Ni H, Zhang X, Fan H. Sedation of mechanically ventilated adults in intensive care unit: a network meta-analysis. Sci Rep 2017;7:44979.
16
Cerra FB, Benitez MR, Blackburn GL, Irwin RS, Jeejeebhoy K, Katz DP, ve ark. Applied nutrition in ICU patients. A consensus statement of the American College of Chest Physicians. Chest 1997;111:769-78.
17
Alberda C, Gramlich L, Jones N, Jeejeebhoy K, Day AG, Dhaliwal R, ve ark. The relationship between nutritional intake and clinical outcomes in critically ill patients: results of an international multicenter observational study. Intensive Care Med 2009;35:1728-37.
18
Thibault R, Pichard C. Nutrition and clinical outcome in intensive care patients. Curr Opin Clin Nutr Metab Care 2010;13:177-83.
19
Weijs PJ, Looijaard WG, Beishuizen A, Girbes AR, Oudemans-van Straaten HM. Early high protein intake is associated with low mortality and energy overfeeding with high mortality in non-septic mechanically ventilated critically ill patients. Crit Care 2014;18:701.
20
Triltsch AE, Welte M, Von Homeyer P, Groe J, Genähr A, Moshirzadeh M, ve ark. Bispectral index-guided sedation with dexmedetomidine in intensive care: a prospective, randomized, double blind, placebo-controlled phase II study. Crit Care Med 2002;30:1007-14.
21
Constantin JM, Momon A, Mantz J, Payen JF, De Jonghe B, Perbet S, et al. Efficacy and safety of sedation with dexmedetomidine in critical care patients: a meta-analysis of randomized controlled trials. Anaesth Crit Care Pain Med 2016;35:7-15.
22
Boyd O, Grounds M, Bennett D. The dependency of oxygen consumption on oxygen delivery in critically III postoperative patients is mimicked by variations in sedation. Chest 1992;101:1619-24.
23
Bruder N, Raynal M, Pellissier D, Courtinat C, Francois G. Influence of body temperature, with or without sedation, on energy expenditure in severe head-injured patients. Crit Care Med 1998;26:568-72.
2024 ©️ Galenos Publishing House